Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants

Author:

Kotaki Ryutaro1ORCID,Moriyama Saya1ORCID,Oishi Shintaro1,Onodera Taishi1ORCID,Adachi Yu1ORCID,Sasaki Eita1ORCID,Ishino Kota1,Morikawa Miwa2ORCID,Takei Hiroaki2,Takahashi Hidenori2ORCID,Takano Tomohiro1ORCID,Nishiyama Ayae1,Yumoto Kohei1ORCID,Terahara Kazutaka1ORCID,Isogawa Masanori1ORCID,Matsumura Takayuki1ORCID,Shinkai Masaharu2ORCID,Takahashi Yoshimasa13ORCID

Affiliation:

1. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.

2. Tokyo Shinagawa Hospital, Tokyo 140-8522, Japan.

3. Institute for Vaccine Research and Development, Hokkaido University, Hokkaido 001-0021, Japan.

Abstract

Immunological imprinting by ancestral SARS-CoV-2 strains is thought to impede the robust induction of Omicron-specific humoral responses by Omicron-based booster vaccines. Here, we analyzed the specificity and neutralization activity of memory B (B mem ) cells after repeated BA.5 exposure in individuals previously imprinted by ancestral strain–based mRNA vaccines. After a second BA.5 exposure, B mem cells with BA.5 spike protein–skewed reactivity were promptly elicited, correlating with preexisting antibody titers. Clonal lineage analysis identified BA.5-skewed B mem cells that had redirected their specificity from the ancestral strain to BA.5 through somatic hypermutations. Moreover, B mem cells with redirected BA.5 specificity exhibited accelerated development compared with de novo B mem cells derived from naïve repertoires. This redirected BA.5 specificity demonstrated greater resilience to viral point mutation and adaptation to recent Omicron variants HK.3 and JN.1, months after the second BA.5 exposure, suggesting that existing B mem cells elicited by older vaccines can redirect their specificity toward newly evolving variants.

Publisher

American Association for the Advancement of Science (AAAS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3